Diagnosing Sepsis

Critical Advancements: The Role of the Pulmonologist in Infectious Disease Prevention

Critical Advancements: Using AIRSUPRA® to Treat Asthma Exacerbations

Complexities of Asthma Treatment: Strategies for Enhanced Management

Critical Advancements: The Impact of an All-Nebulizer Management Strategy in the Acute Care Setting

CHEST 2023 Annual Meeting Recap

Grow, Connect, and Be Inspired at CHEST 2023 Annual Meeting

Enhancing NSCLC Biomarker Testing: Introducing a Practical Clinician Checklist

Matching the Patient with the Delivery Device: When is a Nebulizer the Best Choice?

Antibiotic Use in Suspected Sepsis: Navigating Between Conservative and Aggressive Approaches

The Leading Edge: Efzofitimod, the MostAdvanced Sarcoidosis InvestigationalTreatment

Lung Cancer Biomarker Testing: Improving Turnaround from Presentation to Treatment

Tissue is the Issue: Using EBUS to Acquire & Process Tissue for Biomarker Testing in Adv Lung Cancer

Antibiotic Use in Suspected Sepsis: Navigating Conservative and Aggressive Approaches - PART 2

Antibiotic Use in Suspected Sepsis: Navigating Conservative and Aggressive Approaches - PART 1

CHEST 2023 After Hours

What is Biomarker Testing for Advanced Lung Cancer and Why Is It Important?

Expressing our gratitude for CHEST volunteers

Why CHEST® Pulmonary was created to be open access

What clinicians can expect from CHEST® Pulmonary

Advice for authors looking to submit their research to CHEST® Pulmonary

How CHEST® Critical Care will serve the field

Why CHEST® Critical Care was created to be open access

Advice for authors looking to submit their research to CHEST® Critical Care

Bridging Specialties™: Pulmonary and Primary Care

Bridging Specialties™: Building a team

Bridging Specialties™: Diagnosing ILD

Finding community: Insights from women leaders at CHEST

Getting involved: Insights from women leaders at CHEST

Work Life balance: Insights from women leaders at CHEST